550 Reserve Street, Suite 360
Southlake,  TX  76092

United States
  • Booth: FH15

HeartSciences’ MyoVista® Wavelet ECG (wavECG™) Cardiac Testing Device is a new resting 12-lead electrocardiograph that uses continuous wavelet transform (CWT) signal processing to extract additional frequency information from the acquired ECG signal. This new information is a key aspect of the MyoVista wavECG Algorithm that is designed to detect left ventricular (LV) relaxation abnormalities which are typically the earliest manifestation of left ventricular diastolic dysfunction (LVDD). Extensive research confirms that almost all forms and co-morbidities of heart disease are associated with LVDD including hypertension, diabetes, valvular disease, ischemia, and reduced systolic function. The MyoVista Device provides physicians with new patint information related to a patients heart health.

 Additional Info

ACC.20/WCC Learning Pathways? (select all that apply)
Non Invasive Imaging (Echocardiography/Nuclear/PET/MR and CT)